Tag: biotechnology company
May 17, 2019
Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell Therapeutics Corp.
Jamieson Bondarenko (“Bondarenko”) announced today that he has acquired an aggregate of 1,698,000 common shares (the “Shares”) of BriaCell Therapeutics...
May 15, 2019
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that... May 13, 2019
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders
BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that... May 10, 2019
BriaCell Therapeutics: Process Development Critical to Drug Design Process
BriaCell Therapeutics (TSXV:BCT) (OTCQB:BCTXF) CEO Bill Williams was recently featured in BioPharm International.
May 8, 2019
Pascal Biosciences Announces Formation of Clinical Advisory Board
Pascal Biosciences Inc. (TSXV:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical... May 7, 2019
Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company
Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a... April 25, 2019